FDA Approved: NIACIN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves a supplemental ANDA for NIACIN (nicotinic acid) from Aurobindo Pharma Limited, authorizing the marketing of a generic NIACIN product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Dyslipidemia
• Hyperlipidemia

Drugs mentioned

• Niacin (nicotinic acid)

Snippet

SUPPL AP for NIACIN (NIACIN)